Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 189,000 | 168,400 | 119,800 | 83,900 | 175,100 |
| Depreciation Amortization | 53,700 | 40,300 | 26,400 | 34,500 | 46,400 |
| Income taxes - deferred | -9,900 | 25,200 | 16,300 | 2,800 | -8,700 |
| Accounts receivable | -44,200 | -39,200 | -18,100 | -59,600 | -26,000 |
| Accounts payable and accrued liabilities | 26,900 | 26,500 | 28,200 | 114,600 | 29,100 |
| Other Working Capital | -49,200 | -97,600 | -60,600 | -52,000 | -52,100 |
| Other Operating Activity | 45,500 | -27,900 | -70,100 | -97,700 | 115,000 |
| Operating Cash Flow | $211,800 | $95,700 | $41,900 | $26,500 | $278,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -78,900 | -56,500 | -35,800 | -26,400 | -81,500 |
| Other Investing Activity | 121,200 | 132,000 | 144,400 | 159,900 | -44,000 |
| Investing Cash Flow | $42,300 | $75,500 | $108,600 | $133,500 | $-125,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -2,800 | -2,000 | -2,400 | 300 | -4,900 |
| Debt Repayment | -5,900 | -5,900 | -5,800 | -1,800 | -34,300 |
| Common Stock Issued | 8,100 | 6,600 | 5,600 | 3,300 | 20,500 |
| Common Stock Repurchased | -196,100 | -130,700 | -46,800 | -23,800 | N/A |
| Dividend Paid | -27,100 | -21,200 | -15,100 | -9,000 | -3,800 |
| Other Financing Activity | 12,300 | 12,100 | 1,100 | 400 | -11,100 |
| Financing Cash Flow | $-211,500 | $-141,100 | $-63,400 | $-30,600 | $-33,600 |
| Exchange Rate Effect | -10,100 | -7,100 | 14,700 | 9,300 | 1,900 |
| Beginning Cash Position | 383,300 | 383,300 | 383,300 | 383,300 | 261,700 |
| End Cash Position | 415,800 | 406,300 | 485,100 | 522,000 | 383,300 |
| Net Cash Flow | $32,500 | $23,000 | $101,800 | $138,700 | $121,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 211,800 | 95,700 | 41,900 | 26,500 | 278,800 |
| Capital Expenditure | -78,900 | -56,500 | -35,800 | -26,400 | -81,500 |
| Free Cash Flow | 132,900 | 39,200 | 6,100 | 100 | 197,300 |